Christine is a health economist with more than 10 years’ experience in applied and methodological research. She has experience in the use of qualitative methods alongside discrete choice experiments (DCEs), statistical analysis and modeling of choice data, the measurement of preference heterogeneity, and estimating uptake and trade-off measures such as willingness-to-pay. She has also conducted economic evaluations, systematic reviews, and clinical chart reviews. She has worked in a wide variety of disease areas including, HIV, sexual and reproductive health, cancer, gastrointestinal disorders, rare genetic disorders, and topic areas including health service delivery, diagnostic technologies, injury preventions, vaccines, and novel therapies.
Christine completed her master’s in development economics at Dalhousie University, in Nova Scotia, Canada, and earned her PhD from the London School of Hygiene and Tropical Medicine (LSHTM), where she spent six years as a research fellow. She completed a five year fellowship at the University of Calgary, where she was the recipient of the Alberta Innovates Postgraduate Fellowship, as well as a post-doctoral scholarship from the Institute of Health Economics and the Network of Alberta Health Economists.
Christine has contributed to teaching on several health economics modules at LSHTM Medicine and has supervised graduate students enrolled in the health policy, planning, and financing masters’ program, a joint initiative with the London School of Economics and Political Science. She is an active member of international professional societies, including the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), the Society for Medical Decision Making (SMDM), and the International Health Economics Association (iHEA). Her research has been published in international peer-reviewed journals, including Genetics in Medicine, The Patient: Patient-Centered Outcomes Research, Health Economics Review, Social Science and Medicine, and PLOS One.